Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Early Phase 1

1(16.7%)

6Total

N/A(5)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03324178Not ApplicableCompleted

Use of Neurofeedback to Enhance Attention After Brain Injury

Role: collaborator

NCT03260335Not ApplicableWithdrawn

A Biofeedback Intervention for the Prevention of Challenging Behaviour

Role: collaborator

NCT02913755Not ApplicableCompleted

Motivation and Self-awareness in Acquired Brain Injury (ABI)

Role: collaborator

NCT03231488Not ApplicableUnknown

The Effect of Mindfulness on Cognition and Emotion Following Acquired Brain Injury

Role: collaborator

NCT02584101Not ApplicableCompleted

Acceptance and Commitment Therapy (ACT) and Carers

Role: collaborator

NCT02337114Early Phase 1Completed

Recovery Enhancement From Traumatic Brain Injury Using Acceptance and Commitment Therapy - a Pilot Study.

Role: collaborator

All 6 trials loaded